Breathing and Relaxation Exercises for Asthma: a Randomised Controlled Trial

NCT00400270 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2015-05-28

No results posted yet for this study

Summary

All patients on the GP asthma database in one practice were invited for an asthma physical-therapy assessment, at baseline. Volunteers satisfying the inclusion criteria ie - aged between 16 and 70, able to understand, read and write English, give informed consent, willing to attend the surgery to take part in the trial and with no other serious conditions - were invited to participate in the study. Patients were randomised either to a control group, receiving 2 more assessments at 6 and 12 months, or for comparison to a group receiving 5 physical-therapy treatments of integrated breathing and relaxation exercises (known as the Papworth Method (PM)). The two groups would then be compared at 6 and 12 months.

Hypotheses:

1. The PM of breathing and relaxation training would improve the quality of life for adult patients with asthma in primary care, compared with patients only receiving usual medical care.
2. Anxiety and depression, and symptoms from dysfunctional breathing would reduce compared with the control group.
3. Respiratory function measurements would improve compared with the control group.

Conditions

Interventions

PROCEDURE

Breathing and relaxation exercises: the Papworth Method

Sponsors & Collaborators

  • Welwyn Hatfield Primary Care Trust

    collaborator OTHER
  • University College, London

    collaborator OTHER
  • University College London Hospitals

    lead OTHER

Principal Investigators

  • Professor Robert West, PhD · Department of Epidemiology and Public Health, University College London

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-10-31
Completion
2006-01-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00400270 on ClinicalTrials.gov